Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02803619
What this trial is testing

A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

Who this might be right for
Non-small Cell Lung CancerLeptomeningeal Metastasis
Peking Union Medical College Hospital 60
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)WithdrawnNCT01179269
What this trial is testing

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Loyola University
Testing effectiveness (Phase 2)Ended earlyNCT00664105
What this trial is testing

Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 63
Testing effectiveness (Phase 2)UnknownNCT00663689
What this trial is testing

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Guangdong Provincial People's Hospital 45
Testing effectiveness (Phase 2)Study completedNCT01580735
What this trial is testing

ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Kyowa Kirin Co., Ltd. 40
Not applicableEnded earlyNCT01799135
What this trial is testing

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Dana-Farber Cancer Institute 6
Not applicableUnknownNCT03667885
What this trial is testing

Non-Invasive Diagnostics of Small Renal Masses

Who this might be right for
Renal Cell CarcinomaRenal Tumor
Odense University Hospital 160
Not applicableStudy completedNCT03615443
What this trial is testing

Noninvasive vs. Invasive Lung Evaluation

Who this might be right for
Non-Small Cell Lung Cancer
Guardant Health, Inc. 306
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00988858
What this trial is testing

Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 55
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Early research (Phase 1)Study completedNCT00533585
What this trial is testing

BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 23
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552
What this trial is testing

Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Testing effectiveness (Phase 2)Study completedNCT00212043
What this trial is testing

Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma

Who this might be right for
Non Small Cell Lung Cancer
National University Hospital, Singapore 74
Early research (Phase 1)Study completedNCT00022308
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02535338
What this trial is testing

Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07416058
What this trial is testing

PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC

Who this might be right for
Lung Adenocarcinoma
Guangdong Association of Clinical Trials 61
Not applicableEnded earlyNCT05124743
What this trial is testing

HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors

Who this might be right for
Ovarian CancerEndometrial CancerColo-rectal Cancer+3 more
Alaunos Therapeutics 19
Next Page